News
-
Takeda adds firepower to patient advocacy
- Mon Aug 31
Public Affairs boss Paula Dry has picked a familiar face to lead patient advocacy in Takeda’s growing Oceania Public Affairs team.
Read more -
First targeted lupus treatment fast-tracked to PBS
- Mon Aug 31
PBS funds the first targeted treatment for lupus‑related kidney disease after the PBAC offered Roche a fast-tracked pricing pathway.
Read more -
Sanofi Global Vaccines Head in Sydney
- Mon Aug 31
Dr Jean‑François Toussaint will participate as an expert coach at the Australian Vaccine and Value Chain Conference held in Sydney this week.
Read more -
Astellas names new Australia GM
- Fri Aug 28
Five months after its former Australia GM left, Astellas has named a familiar face as the incoming head of its Australian business.
Read more -
Who speaks loudest on PBAC submissions?
- Fri Aug 28
Patients and supporters have become increasingly vocal over the past decade. Which organisations have the loudest voices, and do they count?
Read more -
Australia presents ‘real challenges’: Neuren CEO
- Fri Aug 28
An Australian biotech CEO acknowledges the challenges of launching products locally as an academic unpacks how Australia could respond to MFN.
Read more -
Guild kicks off campaign for more PBS cash
- Fri Aug 28
The Pharmacy Guild hopes to lock in more PBS investment for its members with a clever campaign that slots neatly into the government’s asks.
Read more -
AUScelerate Signs MoU with Shanghai Centre
- Fri Aug 28
Signs three‑year framework to strengthen Australia–China life sciences links to boost biotech collaboration.
Read more